股骨头
医学
骨髓
主管(地质)
骨髓抽出物
外科
病理
生物
古生物学
作者
Alina R. Baikova,Alexander N. Torgashin,Sergei A. Rodionov,Svetlana Semenovna Rodionova
出处
期刊:Vestnik travmatologii i ortopedii imeni N.N. Priorova
[ECO-vector]
日期:2025-06-26
卷期号:32 (2): 425-438
被引量:1
摘要
BACKGROUND: The use of bone marrow aspirate concentrate in the treatment of avascular necrosis improves outcomes and may delay or prevent joint replacement. However, the method of preparation of bone marrow aspirate concentrate determines both the cellular composition and treatment outcomes. AIM: This study aimed to assess the efficacy and safety of a novel method for obtaining bone marrow aspirate concentrate for the treatment of early-stage avascular necrosis of the femoral head (ANFH). METHODS: The study included 35 patients (64 hip joints) with ARCO stage II–IIIA ANFH. Treatment at the N.N. Priorov National Medical Research Center of Traumatology and Orthopedics involved core decompression combined with administration of bone marrow aspirate concentrate obtained using an original method. The follow-up period was 12 months. Functional outcomes (HHS, WOMAC), pain (VAS), quality of life (SF-36), and ANFH stage and activity (MRI of both joints ≥1.5 T before and 3, 6, and 12 months after treatment; CT before and 6 and 12 months after treatment) were assessed. RESULTS: The proposed method significantly increased cell yield in the bone marrow aspirate concentrate after centrifugation compared to native bone marrow. Following treatment, HHS and WOMAC scores improved significantly, as did pain intensity according to VAS. Progression from stage II to IIIA by ARCO was observed in 4 hips (4 patients), and from stage IIIA to IIIB by ARCO in 5 hips (4 patients). After 12 months, the necrotic lesion size remained stable in all joints. Total hip arthroplasty was required in 4 patients (5 hips; 7.7% of all joints). CONCLUSION: The proposed method for obtaining bone marrow aspirate concentrate enables the injection of the desired amount of cells into the femoral head, restoring normal cellular composition. The efficacy of bone marrow aspirate concentrate has been demonstrated in early-stage avascular necrosis of the femoral head (ARCO stage II), which was observed in the majority of patients in our cohort.
科研通智能强力驱动
Strongly Powered by AbleSci AI